Börsen-Zeitung · @bz
194 followers · 2843 posts · Server hessen.social
cafepharma · @cafepharma
12 followers · 110 posts · Server toot.community

Astellas to acquire eye drug developer Iveric Bio for $5.9B —With negative FDA panel vote, AstraZeneca's Lynparza looks set for narrow nod in prostate cancer—Otsuka, Lundbeck gain FDA nod for longer-acting version of schizophrenia drug Abilify -- See more on our front page news bit.ly/w28kSd

#astellas #mergersandacquisitions #eyehealth #FdA #ProstateCancer #astrazeneca #abilify #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Last updated 1 year ago

DoomsdaysCW · @DoomsdaysCW
806 followers · 9449 posts · Server kolektiva.social

Mongering Returns, Big Time

by Martha Rosenberg, April 3, 2023

"Why the revival? The drug company just received a new drug application for fezolinetant, a drug to treat '' and selling the disease to create 'demand' for a drug is a time honored drug maker tradition. It is buttressed by online 'quizzes' and 'symptom checkers' to help patients self-diagnose the sold condition and go to the doctor requesting the new drug. 'Unbranded' advertising, in which a disease rather than a drug is sold, is often mistaken for messages from the CDC by the public which helps the sell."

Read more: counterpunch.org/2023/04/03/me

counterpunch.org/2023/04/03/me

#menopause #astellas #vms #bigpharma #marketing

Last updated 1 year ago

cafepharma · @cafepharma
12 followers · 94 posts · Server toot.community

FDA approves Keytruda/Padcev combo in advanced urothelial cancer — Record growth in U.S. life sciences real estate footprint — Diabesity drugs and their free ‘contract sales force’ -- See more on our front page news bit.ly/w28kSd

#FdA #merck #astellas #urothelialcancer #realestate #diabetes #obesity #novonordisk #elililly #keytruda #lifesciences #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Last updated 1 year ago

cafepharma · @cafepharma
12 followers · 94 posts · Server toot.community

US again spurns march-in campaign to slash cost of Pfizer, Astellas' Xtandi — Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test— Boston Scientific, Medtronic expected to quickly capture new atrial fibrillation market -- See more on our front page news bit.ly/w28kSd

#pfizer #astellas #ProstateCancer #roche #elililly #diagnostics #medtech #alzheimers #AtrialFibrillation #afib #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Last updated 1 year ago

cafepharma · @cafepharma
12 followers · 94 posts · Server toot.community

Alzheimer's Association campaigns for broader Leqembi coverage — FDA reverses course; will hold adcomm for Sarepta’s DMD gene therapy— Pfizer and Astellas report positive data from prostate cancer therapy trial -- See more on our front page news bit.ly/w28kSd

#alzheimers #eisai #biogen #FdA #dmd #Duchenne #pfizer #astellas #clinicaltrials #ProstateCancer #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Last updated 1 year ago

cafepharma · @cafepharma
10 followers · 56 posts · Server toot.community

Vaccines slip, Dupixent climbs for Sanofi as it readies multiple launches in 2023 — Astellas taps new CEO —Biogen and Sage get FDA priority review of depression med zuranolone -- See more on our front page news bit.ly/w28kSd

#Sanofi #earnings #druglaunches #astellas #ceos #biogen #sagetherapeutics #FdA #depression #postpartumdepression #priorityreview #pharma #pharmanews #biotech #biotechnology #biopharma #cafepharma

Last updated 2 years ago

cafepharma · @cafepharma
8 followers · 29 posts · Server toot.community

AZ wins patent fight with Viatris, gains more exclusivity for blockbuster Symbicort — AbbVie leaves PhRMA, BIO: reports —Astellas’ Phase III gastric cancer therapy trial meets primary endpoint -- See more on our front page news bit.ly/w28kSd

#astrazeneca #patents #symbicort #bio #phrma #abbvie #astellas #clinicaltrials #gastriccancer #pharma #pharmanews #biotech #biotechnology #biopharma #cafepharma

Last updated 2 years ago